Aptevo Therapeutics Inc. (APVO) stock
APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46−0.09 (-15.97%)
Close on Nov 17, 2026Market cap $830.71KP/E –Yield –
Aptevo Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Aptevo Therapeutics's price to book ratio was 0.2× on Nov 11, 2026, against 1.1× a year earlier. Over the last 4 years it ranged from 0.2× to 475.1×, with a median of 3.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −0.2 |
| 2025 | Dec 31, 2025 | 0.4× | −8.6 |
| 2024 | Dec 31, 2024 | 9.0× | −147.5 |
| 2023 | Dec 29, 2023 | 156.5× | −227.8 |
| 2019 | Apr 30, 2019 | 384.3× | −76.4 |
| 2018 | Dec 31, 2018 | 460.7× | +72.9 |
| 2017 | Aug 31, 2017 | 387.8× | −36.8 |
| 2016 | Nov 30, 2016 | 424.6× | – |
See a number that looks wrong?